Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trissel, L.
Right arrow Articles by Gentempo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trissel, L.
Right arrow Articles by Gentempo, J.
American Journal of Health-System Pharmacy, Vol 60, Issue 18, 1853-1855
Copyright © 2003 by American Society of Health-System Pharmacists

Articles

Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding

LA Trissel, AB Ogundele, DS Ingram, CA Saenz, and JA Gentempo


A benchmark contamination rate for prefilled syringe compounding was determined by using a medium-fill-simulation method. One thousand thirty-five 1-mL tuberculin syringes were aseptically filled with 0.9 mL of sterile soybean-casein digest medium and capped. These syringes were placed into clear nonsterile plastic bags and incubated at 35 degrees C for seven days, then inspected for cloudiness or colony formation indicative of bacterial growth. The operation was performed by two certified pharmacy technicians in an ISO Class 5 vertical-airflow biological safety cabinet in a typical inpatient pharmacy compounding area over two days. The technicians wore protective garments and gloves and followed standard procedures of preparing sterile injections. The adequacy of the methodology was verified by using four syringes that contained deliberately contaminated medium and incubating them along with 15 aseptically prepared syringes at 35 degrees C for seven days. Colony formation in the four syringes containing contaminated medium was directly observed and differentiated from the control syringes, which confirms the validity of the method. No bacterial growth was detected in any of the 1035 medium-filled syringes studied. Therefore, the contamination rate for aseptic compounding operation was less than 0.1%. Medium-fill-simulation testing of 1035 prefilled tuberculin syringes yielded no contamination. A contamination rate of less than 0.1% should be achievable and expected for this type of low-risk pharmacy preparation after pharmacies validate their own compounding operation.
 



This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
M. Hellums, S. P. Alverson, and M. R. Monk-Tutor
Instruction on compounded sterile preparations at U.S. schools of pharmacy
Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2267 - 2274.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
L. A. Trissel, J. A. Gentempo, L. M. Saenz, M. Y. Woodard, and C. H. Angeles
Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations
Am. J. Health Syst. Pharm., April 15, 2007; 64(8): 837 - 841.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. R. Held, E. M. Begier, D. S. Beardsley, F. A. Browne, R. A. Martinello, R. S. Baltimore, L. C. McDonald, B. Jensen, J. L. Hadler, and L.-M. Dembry
Life-Threatening Sepsis Caused by Burkholderia cepacia From Contaminated Intravenous Flush Solutions Prepared by a Compounding Pharmacy in Another State
Pediatrics, July 1, 2006; 118(1): e212 - e215.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
M. Thomas, M. D. Sanborn, and R. Couldry
I.V. admixture contamination rates: Traditional practice site versus a class 1000 cleanroom
Am. J. Health Syst. Pharm., November 15, 2005; 62(22): 2386 - 2392.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
L. A. Trissel, J. A. Gentempo, R. W. Anderson, and J. D. Lajeunesse
Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding
Am. J. Health Syst. Pharm., February 1, 2005; 62(3): 285 - 288.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Health-System Pharmacists.